17 Long-term effects of GLP-1 in animal studies demonstrated increases in beta-cell mass and beta-cell efficiency
We can adjust your dosing regimen to fit what YOU need
What happens if I stop the medication
Novo Nordisk (Wegovy / semaglutide) first mover, biggest revenue base, but facing supply constraints and pricing pressure
In this retrospective, observational study, we analysed glycated haemoglobin (HbA1c) and weight following switching to semaglutide from any other GLP-1 RA, using US electronic health records and prescription data
Semaglutide crosses the blood-brain barrier only minimally, primarily via circumventricular organs, as shown in prior, disclosed Novo Nordisk studies